MSN Laboratories Private Ltd. et al. v. Bausch Health Ireland Limited et al. > Summary
Court Case Number IPR2023-00016
Filing Date Oct 12, 2022
Institution Decision Date Dec 14, 2022
Decision Date Sep 8, 2023
Court Patent Trial and Appeal Board
Status Final Written Decision - Appeale
Appeal2024-1011
Administrative JudgesMichael A. Valek, Tina E. Hulse, Cynthia M. Hardman
Judge Writing the Final DecisionMichael A. Valek
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6
Claims Instituted: 1, 2, 3, 4, 5, 6
Petitioner
Petitioner Attorneys
9MSN Laboratories
Attorney Name: Andrew O. Larsen
Merchant & Gould
MSN Laboratories
Attorney Name: Christopher J. Sorenson
Merchant & Gould
MSN Laboratories
Attorney Name: Melissa M. Hayworth
Merchant & Gould
Salix Pharmaceuticals
Attorney Name: Jad Allen Mills
Wilson Sonsini Goodrich & Rosati
Salix Pharmaceuticals
Attorney Name: Dennis D. Gregory
Wilson Sonsini Goodrich & Rosati
Salix Pharmaceuticals
Attorney Name: Richard L. Torczon Jr.
Wilson Sonsini Goodrich & Rosati
Salix Pharmaceuticals
Attorney Name: Nicole W. Stafford
Wilson Sonsini Goodrich & Rosati
Attorney Name: Richard J. Berman
ArentFox Schiff
Attorney Name: Bradford C. Frese
ArentFox Schiff
Patent Owner Attorneys
9Salix Pharmaceuticals
Attorney Name: Kyu Yun Kim
Finnegan, Henderson, Farabow, Garrett & Dunner
Salix Pharmaceuticals
Attorney Name: Lauren J. Robinson
Finnegan, Henderson, Farabow, Garrett & Dunner
Salix Pharmaceuticals
Attorney Name: Caitlin E. O'Connell
Finnegan, Henderson, Farabow, Garrett & Dunner
Salix Pharmaceuticals
Attorney Name: Bryan C. Diner
Finnegan, Henderson, Farabow, Garrett & Dunner
Salix Pharmaceuticals
Attorney Name: Justin J. Hasford
Finnegan, Henderson, Farabow, Garrett & Dunner
Salix Pharmaceuticals
Attorney Name: Joshua L. Goldberg
Finnegan, Henderson, Farabow, Garrett & Dunner
Salix Pharmaceuticals
Attorney Name: Kathryn Doyle
Centre Square West
Attorney Name: Caitlin E. O'Connell
Finnegan, Henderson, Farabow, Garrett & Dunner
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07041786 | Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis | May 9, 2006 |
